Need Help?

Acute myeloid leukemia single cell RNA-seq (Diagnosis and Relapse)

To gain insight into the clonal heterogeneity of diagnosis (Dx) and relapse (Re) pairs, we employed single-cell RNA-seq (SORT-seq) to longitudinally profile two t(8;21) (AML1-ETO = RUNX1-RUNX1T1), and four FLT3-ITD AML cases. All the samples are Bone marrow aspirates.

Request Access

Example policy

DATA ACCESS AGREEMENT These terms and conditions govern access to the managed access datasets (details of which are set out in Appendix I) to which the User Institution has requested access. The User Institution agrees to be bound by these terms and conditions. Definitions Authorised Personnel: The individuals at the User Institution to whom XXXXX grants access to the Data. This includes the User, the individuals listed in Appendix II and any other individuals for whom the User Institution subsequently requests access to the Data. Details of the initial Authorised Personnel are set out in Appendix II. Data: The managed access datasets to which the User Institution has requested access. Data Producers: XXXXX and the collaborators listed in Appendix I responsible for the development, organisation, and oversight of these Data. External Collaborator: A collaborator of the User, working for an institution other than the User Institution. Project: The project for which the User Institution has requested access to these Data. A description of the Project is set out in Appendix II. Publications: Includes, without limitation, articles published in print journals, electronic journals, reviews, books, posters and other written and verbal presentations of research. Research Participant: An individual whose data form part of these Data. Research Purposes: Shall mean research that is seeking to advance the understanding of genetics and genomics, including the treatment of disorders, and work on statistical methods that may be applied to such research. User: The principal investigator for the Project. User Institution(s): The Institution that has requested access to the Data. XXXXX: Your Institution details here 1. The User Institution agrees to only use these Data for the purpose of the Project (described in Appendix II) and only for Research Purposes. The User Institution further agrees that it will only use these Data for Research Purposes which are within the limitations (if any) set out in Appendix I. 2. The User Institution agrees to preserve, at all times, the confidentiality of these Data. In particular, it undertakes not to use, or attempt to use these Data to compromise or otherwise infringe the confidentiality of information on Research Participants. Without prejudice to the generality of the foregoing, the User Institution agrees to use at least the measures set out in Appendix I to protect these Data. 3. The User Institution agrees to protect the confidentiality of Research Participants in any research papers or publications that they prepare by taking all reasonable care to limit the possibility of identification. 4. The User Institution agrees not to link or combine these Data to other information or archived data available in a way that could re-identify the Research Participants, even if access to that data has been formally granted to the User Institution or is freely available without restriction. 5. The User Institution agrees only to transfer or disclose these Data, in whole or part, or any material derived from these Data, to the Authorised Personnel. Should the User Institution wish to share these Data with an External Collaborator, the External Collaborator must complete a separate application for access to these Data. 6. The User Institution agrees that the Data Producers, and all other parties involved in the creation, funding or protection of these Data: a) make no warranty or representation, express or implied as to the accuracy, quality or comprehensiveness of these Data; b) exclude to the fullest extent permitted by law all liability for actions, claims, proceedings, demands, losses (including but not limited to loss of profit), costs, awards damages and payments made by the Recipient that may arise (whether directly or indirectly) in any way whatsoever from the Recipient’s use of these Data or from the unavailability of, or break in access to, these Data for whatever reason and; c) bear no responsibility for the further analysis or interpretation of these Data. 7. The User Institution agrees to follow the Fort Lauderdale Guidelines (http://www.wellcome.ac.uk/stellent/groups/corporatesite/@policy_communications/documents/web_document/wtd003207.pdf ) and the Toronto Statement (http://www.nature.com/nature/journal/v461/n7261/full/461168a.html). This includes but is not limited to recognising the contribution of the Data Producers and including a proper acknowledgement in all reports or publications resulting from the use of these Data. 8. The User Institution agrees to follow the Publication Policy in Appendix III. This includes respecting the moratorium period for the Data Producers to publish the first peer-reviewed report describing and analysing these Data. 9. The User Institution agrees not to make intellectual property claims on these Data and not to use intellectual property protection in ways that would prevent or block access to, or use of, any element of these Data, or conclusion drawn directly from these Data. 10. The User Institution can elect to perform further research that would add intellectual and resource capital to these data and decide to obtain intellectual property rights on these downstream discoveries. In this case, the User Institution agrees to implement licensing policies that will not obstruct further research and to follow the U.S. National Institutes of Health Best Practices for the Licensing of Genomic Inventions (2005) (https://www.icgc.org/files/daco/NIH_BestPracticesLicensingGenomicInventions_2005_en.pdf ) in conformity with the Organisation for Economic Co-operation and Development Guidelines for the Licensing of the Genetic Inventions (2006) (http://www.oecd.org/science/biotech/36198812.pdf ). 11. The User Institution agrees to destroy/discard the Data held, once it is no longer used for the Project, unless obliged to retain the data for archival purposes in conformity with audit or legal requirements. 12. The User Institution will notify XXXXX within 30 days of any changes or departures of Authorised Personnel. 13. The User Institution will notify XXXXX prior to any significant changes to the protocol for the Project. 14. The User Institution will notify XXXXX as soon as it becomes aware of a breach of the terms or conditions of this agreement. 15. XXXXX may terminate this agreement by written notice to the User Institution. If this agreement terminates for any reason, the User Institution will be required to destroy any Data held, including copies and backup copies. This clause does not prevent the User Institution from retaining these data for archival purpose in conformity with audit or legal requirements. 16. The User Institution accepts that it may be necessary for the Data Producers to alter the terms of this agreement from time to time. As an example, this may include specific provisions relating to the Data required by Data Producers other than XXXXX. In the event that changes are required, the Data Producers or their appointed agent will contact the User Institution to inform it of the changes and the User Institution may elect to accept the changes or terminate the agreement. 17. If requested, the User Institution will allow data security and management documentation to be inspected to verify that it is complying with the terms of this agreement. 18. The User Institution agrees to distribute a copy of these terms to the Authorised Personnel. The User Institution will procure that the Authorised Personnel comply with the terms of this agreement. 19. This agreement (and any dispute, controversy, proceedings or claim of whatever nature arising out of this agreement or its formation) shall be construed, interpreted and governed by the laws of England and Wales and shall be subject to the exclusive jurisdiction of the English courts.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
RNASeq

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Located in
EGAF00005725222 1637942880451 426.7 MB
EGAF00005725223 1637942880451 418.1 MB
EGAF00005725224 1637942940486 768.1 MB
EGAF00005725225 1637942820524 666.8 MB
EGAF00005725226 1637943121811 752.0 MB
EGAF00005725227 1637942880451 653.1 MB
EGAF00005725228 1637942760611 987.8 MB
EGAF00005725229 1637943000621 864.6 MB
EGAF00005725230 1637942880451 445.7 MB
EGAF00005725231 1637942820524 206.2 MB
EGAF00005725232 1637942701209 957.2 MB
EGAF00005725233 1637942940485 823.1 MB
EGAF00005725234 1637942820524 729.2 MB
EGAF00005725235 1637942701209 630.8 MB
EGAF00005725236 1637943000621 953.7 MB
EGAF00005725237 1637942701209 421.7 MB
EGAF00005725238 1637942701209 659.4 MB
EGAF00005725239 1637942760611 597.8 MB
EGAF00005725240 1637942940485 707.9 MB
EGAF00005725241 1637943062090 596.1 MB
EGAF00005725242 1637943180235 370.9 MB
EGAF00005725243 1637942760611 167.3 MB
EGAF00005725244 1637943000621 751.4 MB
EGAF00005725245 1637942820524 706.8 MB
EGAF00005725246 1637942880451 802.9 MB
EGAF00005725247 1637942820524 672.5 MB
EGAF00005725248 1637942701209 690.1 MB
EGAF00005725249 1637942701209 671.5 MB
EGAF00005725250 1637942760611 483.6 MB
EGAF00005725251 1637943000621 436.4 MB
EGAF00005725252 1637942701209 713.7 MB
EGAF00005725253 1637942760611 712.8 MB
EGAF00005725254 1637944200206 5.4 GB
EGAF00005725255 1637943721263 2.3 GB
EGAF00005725256 1637942760611 1.2 GB
EGAF00005725257 1637943180235 1.1 GB
EGAF00005725258 1637942940485 501.4 MB
EGAF00005725259 1637942820524 487.5 MB
EGAF00005725260 1637943062090 611.9 MB
EGAF00005725261 1637942760611 566.9 MB
EGAF00005725262 1637942701209 549.2 MB
EGAF00005725263 1637943000621 507.3 MB
EGAF00005725264 1637942760611 1.1 GB
EGAF00005725265 1637942880451 512.6 MB
EGAF00005725266 1637943000621 928.4 MB
EGAF00005725267 1637942880451 936.0 MB
EGAF00005725268 1637942880451 527.6 MB
EGAF00005725269 1637942760611 238.5 MB
EGAF00005725270 1637943180235 734.1 MB
EGAF00005725271 1637942940485 331.0 MB
EGAF00005725272 1637942940485 787.3 MB
EGAF00005725273 1637942580680 684.5 MB
EGAF00005725274 1637943660950 2.2 GB
EGAF00005725275 1637943301166 2.1 GB
EGAF00005725276 1637943000621 986.7 MB
EGAF00005725277 1637943121811 1.0 GB
EGAF00005725278 1637942520151 127.2 MB
EGAF00005725279 1637942640516 116.7 MB
EGAF00005725280 1637943420258 1.2 GB
EGAF00005725281 1637942580680 564.4 MB
60 Files (48.7 GB)